A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response
Human Gene Therapy · 2024
DOI: 10.1089/hum.2022.206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, 2024. Verfasst von Cong Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Hepato-Pancreato-Biliary Surgery, Institute of Hepatobiliary Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, Chi…. Hauptthemen laut MEDLINE: Oncolytic Viruses, Carcinoma, Hepatocellular, Liver Neoplasms, Oncolytic Virotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Hepato-Pancreato-Biliary Surgery, Institute of Hepatobiliary Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
- School of Basic Medical Sciences, Inner Mongolia Medical University, Hohhot, China.
- The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
- Department of Respiratory, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen, China.
ORCID-Profile: Cong Li
Zitieren
APA
Li, C., Tian, Y., Sun, F., Lei, G., Cheng, J., Tian, C., Yu, H., Deng, Z., Lu, S., Wang, L., Xiao, R., Bai, C., & Yang, P. (2024). A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response. Human Gene Therapy. https://doi.org/10.1089/hum.2022.206
Vancouver
Li C, Tian Y, Sun F, Lei G, Cheng J, Tian C, et al. A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response. Human Gene Therapy. 2024. doi:10.1089/hum.2022.206
BibTeX
@article{Li2024,
author = {Li, Cong and Tian, Yuying and Sun, Fang and Lei, Guanglin and Cheng, Jinxia and Tian, Chongyu and Yu, Hongyu and Deng, Zhuoya and Lu, Shuai and Wang, Lishi and Xiao, Ruixue and Bai, Changqing and Yang, Penghui},
title = {A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response},
journal = {Human Gene Therapy},
year = {2024},
doi = {10.1089/hum.2022.206}
}
EUVIMED